Sep 14, 2026 05:01PM
Sep 14, 2026 05:00PM
Jul 30, 2026 05:00PM
Apr 30, 2026 05:00PM
Feb 5, 2026 05:00PM
Jan 13, 2026 05:00PM
Jan 13, 2026 05:00PM Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate
Jan 9, 2026 07:58AM
Dec 17, 2025 05:00PM
Dec 17, 2025 05:00PM
Oct 30, 2025 05:00PM
Oct 16, 2025 08:00AM
Oct 16, 2025 08:00AM
Jul 31, 2025 05:00PM Aptar Reports Second Quarter 2025 Results
Jul 15, 2025 05:00PM
Jul 15, 2025 05:00PM
May 1, 2025 05:03PM
Apr 16, 2025 08:02AM
Apr 16, 2025 08:00AM
Feb 6, 2025 05:17PM
Oct 24, 2024 05:00PM Aptar Reports Third Quarter 2024 Results
Sep 23, 2024 05:01PM
Sep 23, 2024 05:00PM
Aug 15, 2024 05:00PM
Jul 25, 2024 05:00PM
Apr 25, 2024 05:00PM
Feb 8, 2024 05:00PM
Dec 4, 2023 08:37AM AptarGroup (ATR) Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers
Dec 4, 2023 08:30AM
Sep 22, 2022 08:30AM
Oct 25, 2021 08:30AM
Apr 6, 2021 07:04AM
Apr 6, 2021 07:00AM
Feb 15, 2021 05:00PM
May 8, 2020 08:40AM AptarGroup (ATR) Submits Application for Emergency Use Authorization to German Regulatory Agency BfArM for ActivShield FFP2 Decontamination System
May 8, 2020 08:30AM
Apr 3, 2020 05:58PM
Feb 20, 2020 05:00PM
Dec 9, 2019 08:32AM
Dec 9, 2019 08:30AM
Oct 22, 2019 05:00PM
Oct 21, 2019 09:30AM Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment
Sep 10, 2019 07:30AM
Jul 25, 2019 10:31AM
Mar 20, 2019 09:28AM
Mar 18, 2019 05:00PM
Jan 18, 2019 08:30AM
May 2, 2017 05:00PM
Mar 22, 2017 05:00PM Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time for a Prescription Dry Eye Product in the US with RESTASIS MULTIDOSE™

331,671 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All